Hypoxia and glioblastoma therapy

由 Yang, Chunzhang, Hong, Christopher S., Zhuang, Zhengping
發表在 Aging (Albany NY) (2015)

Application of Peptide Nucleic Acid-based Assays Toward Detection of Somatic Mosaicism

由 Hong, Christopher S, Yang, Chunzhang, Zhuang, Zhengping
發表在 Mol Ther Nucleic Acids (2016)

TMIC-18. MICROENVIRONMENT-DERIVED MITOCHONDRIA PRIME GLIOMA CHEMO-RESISTANCE BY POTENTIATED NAD METABOLISM AND BASE EXCISION DNA REPAIR

由 Liu, Yang, Gilbert, Mark, Yang, Chunzhang
發表在 Neuro Oncol (2017)

Evaluating In Vitro DNA Damage Using Comet Assay

由 Lu, Yanxin, Liu, Yang, Yang, Chunzhang
發表在 J Vis Exp (2017)

An innovative approach to the treatment of Gaucher disease and possibly other metabolic disorders of the brain

由 Brady, Roscoe O., Yang, Chunzhang, Zhuang, Zhengping
發表在 J Inherit Metab Dis (2012)

Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction

由 Jochmanová, Ivana, Yang, Chunzhang, Zhuang, Zhengping, Pacak, Karel
出版 2013

EXTH-74. IMPAIRED PARP1 DNA REPAIR DEFINES CHEMO-SENSITIVITY IN IDH1 MUTANT CELL

由 Lu, Yanxin, Liu, Yang, Wu, Jing, Yang, Chunzhang
發表在 Neuro Oncol (2017)

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies

由 Pang, Ying, Liu, Yang, Pacak, Karel, Yang, Chunzhang
發表在 Cancers (Basel) (2019)

EXTH-03. TRIPTOLIDE, A NOVEL THERAPEUTIC AGENT FOR IDH1-MUTATED GLIOMA

由 Yu, Di, Liu, Yang, Xu, Guowang, Yang, Chunzhang
發表在 Neuro Oncol (2019)

Brusatol, an NRF2 inhibitor for future cancer therapeutic

由 Cai, Sabrina J., Liu, Yang, Han, Sue, Yang, Chunzhang
發表在 Cell Biosci (2019)

Maotai Ameliorates Diethylnitrosamine-Initiated Hepatocellular Carcinoma Formation in Mice

由 Yi, Xu, Long, Li, Yang, Chunzhang, Lu, Yingying, Cheng, Mingliang
出版 2014

ATPS-96 HISTONE DEACETYLASE INHIBITORS REPRESS HYPOXIA SIGNALING THROUGH AFFECTING HSP90

由 Yang, Chunzhang, Zhang, Chao, Feldman, Michael, Dmitriev, Pauline, Zhuang, Zhengping
發表在 Neuro Oncol (2015)

Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy

由 Lu, Yanxin, Liu, Yang, Pang, Ying, Pacak, Karel, Yang, Chunzhang
發表在 Pharmacol Ther (2018)

EXTH-80. IMPAIRED PARP1 DNA REPAIR DEFINES CHEMO-SENSITIVITY IN IDH1-MUTATED CELL

由 Lu, Yanxin, Liu, Yang, Gilbert, Mark, Wu, Jing, Yang, Chunzhang
發表在 Neuro Oncol (2018)

EXTH-81. TARGETING Nrf2 ANTIOXIDATIVE PATHWAY AS A NOVEL THERAPEUTIC STRATEGY FOR IDH1-MUTATED CANCERS

由 Liu, Yang, Lu, Yanxin, Celiku, Orieta, Li, Aiguo, Yang, Chunzhang
發表在 Neuro Oncol (2018)

CADD-09. TARGETING Nrf2 ANTIOXIDATIVE PATHWAY AS A NOVEL THERAPEUTIC STRATEGY FOR IDH1-MUTATED CANCERS

由 Liu, Yang, Lu, Yanxin, Celiku, Orieta, Li, Aiguo, Yang, Chunzhang
發表在 Neuro Oncol (2018)

EXTH-04. BLOCKADE OF NRF2/GLUTATHIONE METABOLISM AS A SYNTHETIC LETHALITY APPROACH FOR IDH1-MUTATED GLIOMA

由 Liu, Yang, Lu, Yanxin, Celiku, Orieta, Li, Aiguo, Yang, Chunzhang
發表在 Neuro Oncol (2019)

Proteostasis modulators prolong missense VHL protein activity and halt tumor progression

由 Yang, Chunzhang, Huntoon, Kristin, Ksendzovsky, Alexander, Zhuang, Zhengping, Lonser, Russell R.
出版 2013

New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma

由 Dimitrov, Lilia, Hong, Christopher S., Yang, Chunzhang, Zhuang, Zhengping, Heiss, John D.
發表在 Int J Med Sci (2015)

Somatic mosaicism of EPAS1 mutations in the syndrome of paraganglioma and somatostatinoma associated with polycythemia

由 Yang, Chunzhang, Hong, Christopher S, Prchal, Josef T, Balint, Melina T, Pacak, Karel, Zhuang, Zhengping
發表在 Hum Genome Var (2015)